Fexofenadine Use in Gastroesophageal Reflux Symptoms

NCT03425097 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
11
Enrollment
OTHER
Sponsor class

Stopped The study was terminated due to insufficient evidence for Fexofenadine efficacy to treat GERD symptoms after the interim analysis.

Conditions

Interventions

Sponsor

Stanford University